SCHEMBL7873807

SCHEMBL7873807

CCN(CC)Cc1ccccc1COc1ccc2cc(C(=O)N=C(N)NC)[nH]c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 3/20 0.40
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.39
RXFP1 Q9HBX9 1/20 0.39
PDGFRB P09619 4/20 0.37
PDGFRA P16234 4/20 0.37
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
HPGD P15428 1/20 0.35
SRD5A2 P31213 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CFD P00746 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7882025 0.91 MEN1 (0.42) FLT3KMT2AMEN1RXFP1PDGFRB
SCHEMBL7873709 0.88 HRH3 (0.47) FLT3KMT2AMEN1RXFP1PDGFRB
SCHEMBL7884907 0.88 FLT3 (0.43) FLT3KMT2AMEN1RXFP1PDGFRB
SCHEMBL7882351 0.87 CFD (0.44) FLT3KMT2AMEN1RXFP1PDGFRB
SCHEMBL7885059 0.86 MDM4 (0.33) KDM4EALDH1A1GAAMAPTSMN1; SMN2
SCHEMBL7881849 0.84 MAOB (0.36) ACHEMAOB
SCHEMBL7879928 0.83 FLT3 (0.46) FLT3KMT2APDGFRBPDGFRAGAA
SCHEMBL7873242 0.82 MAOB (0.45) FLT3PDGFRBPDGFRAKDM4EMAOB
SCHEMBL7884463 0.82 MEN1 (0.38) FLT3KMT2AMEN1KDM4EALDH1A1
Hydrochloric Acid SCHEMBL7877491 0.82 FLT3 (0.57) FLT3KMT2AMEN1RXFP1PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1067988-C Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 2001-07-04 CN disclosed
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
CN-1136038-A Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 1996-11-20 CN disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed